Want to see LMRI full AI Analyst Report?
LMRI Stock Chart & Stats
$12.42
$0.08(0.69%)
At close: 4:00 PM EDT
$12.42
$0.08(0.69%)
Day’s Range― - ―
52-Week Range$6.45 - $19.45
Previous Close$11.8
Volume328.02K
Average Volume (3M)596.29K
Market Cap
$1.19B
Enterprise Value$1.99K
Total Cash (Recent Filing)$69.70M
Total Debt (Recent Filing)$975.35M
Price to Earnings (P/E)―
Beta1.15
Next Earnings
Apr 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.33
Shares Outstanding96,074,974
10 Day Avg. Volume398,784
30 Day Avg. Volume596,288
Financial Highlights & Ratios
PEG Ratio0.82
Price to Book (P/B)2.24
Price to Sales (P/S)1.28
P/FCF Ratio-205.07
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$17.50Price Target Upside40.90% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)0.76
Revenue Forecast (FY)$1.07B
Bulls Say, Bears Say
Bulls Say
Advanced Imaging Mix And Volume GrowthA rising advanced-imaging mix supports structurally higher reimbursement and margin potential. PET and MRI growth, alongside increasing capacity, can strengthen Lumexa’s service mix and improve long-term revenue quality.
Deleveraging And Lower Interest CostsDebt reduction and lower borrowing costs improve financial flexibility and reduce pressure on future cash generation. Continued deleveraging could make the balance sheet more resilient while supporting investment in imaging capacity.
Expansion Through Partnerships And New CentersA repeatable expansion model using joint ventures, acquisitions, and de novo centers can broaden geographic reach and create durable capacity growth. New sites and partnerships also provide a pipeline for future volume and revenue expansion.
Bears Say
Persistently Weak Bottom-Line ProfitabilityDespite revenue growth and positive EBIT, sustained net losses show that operating earnings are not yet translating reliably into shareholder profitability. This limits internal capital generation and leaves results vulnerable to financing and cost pressures.
High Debt And Restrictive Credit TermsThe large secured debt burden leaves Lumexa exposed to refinancing, interest-rate, and covenant risks even after recent deleveraging. Collateral and transaction restrictions may constrain acquisitions, dividends, and strategic flexibility if performance weakens.
Volatile Earnings-to-Cash ConversionThe latest quarter showed strong cash generation, but the broader record remains volatile, with negative 2025 free cash flow and modest expected full-year conversion. Working-capital needs or investment spending could continue to limit debt reduction.
Lumexa Imaging Holdings, Inc. News
LMRI FAQ
What was Lumexa Imaging Holdings, Inc.’s price range in the past 12 months?
Lumexa Imaging Holdings, Inc. lowest stock price was $6.45 and its highest was $19.45 in the past 12 months.
What is Lumexa Imaging Holdings, Inc.’s market cap?
Lumexa Imaging Holdings, Inc.’s market cap is $1.19B.
When is Lumexa Imaging Holdings, Inc.’s upcoming earnings report date?
Lumexa Imaging Holdings, Inc.’s upcoming earnings report date is Apr 01, 2027 which is in 219 days.
How were Lumexa Imaging Holdings, Inc.’s earnings last quarter?
Lumexa Imaging Holdings, Inc. released its earnings results on Aug 12, 2026. The company reported $0.2 earnings per share for the quarter, beating the consensus estimate of $0.148 by $0.052.
Is Lumexa Imaging Holdings, Inc. overvalued?
According to Wall Street analysts Lumexa Imaging Holdings, Inc.’s price is currently Undervalued.
Does Lumexa Imaging Holdings, Inc. pay dividends?
Lumexa Imaging Holdings, Inc. does not currently pay dividends.
What is Lumexa Imaging Holdings, Inc.’s EPS estimate?
Lumexa Imaging Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lumexa Imaging Holdings, Inc. have?
Lumexa Imaging Holdings, Inc. has 96,074,974 shares outstanding.
What happened to Lumexa Imaging Holdings, Inc.’s price movement after its last earnings report?
Lumexa Imaging Holdings, Inc. reported an EPS of $0.2 in its last earnings report, beating expectations of $0.148. Following the earnings report the stock price went up 4.007%.
Which hedge fund is a major shareholder of Lumexa Imaging Holdings, Inc.?
Currently, no hedge funds are holding shares in LMRI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Lumexa Imaging Holdings, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$17.50 (40.90% Upside)
$17.50 (40.90% Upside)
Blogger Sentiment
Bullish
LMRI Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 592.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 5.1%
Last 30 Days ▼ 5.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Company Description
Lumexa Imaging Holdings, Inc.
Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States. These facilities deliver a comprehensive range of outpatient medical imaging solutions, encompassing advanced procedures like Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) scans, in addition to standard diagnostic and screening services such as X-rays, ultrasounds, and mammography. The company was founded in 2018 and its primary base of operations is in Raleigh, North Carolina.
LMRI Company Deck
LMRI Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational momentum and financial improvement: revenue and system-wide growth, record advanced modality mix, improved cash generation and deleveraging, PET and JV expansion, and platform/technology investment. Offsetting items include margin compression from public-company costs and elevated stock-based compensation, higher G&A, some routine-scan and payor-mix headwinds, and modeling complexity from JV pass-throughs. Management reiterated and narrowed guidance, signifying confidence in execution. Overall, positives around growth, cash flow, strategic partnerships and balance-sheet improvement materially outweigh the manageable cost and timing challenges discussed.View all LMRI earnings summariesLMRI Stock 12 Month Forecast
Average Price Target
$17.50
▲(40.90% Upside)
Ownership Overview
0.64% Insiders
12.41% Mutual Funds
10.37% Other Institutional Investors
74.20% Public Companies and
Individual Investors